Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …

Gut microbiota is a microecosystem composed of various microorganisms. It plays an
important role in human metabolism, and its metabolites affect different tissues and organs …

Dyslipidemia is a multifaceted condition with various genetic and environmental factors
contributing to its pathogenesis. Further, this condition represents an important risk factor for …

Functional gastrointestinal disorders (FGIDs), chronic disorders characterized by either
abdominal pain, altered intestinal motility, or their combination, have a worldwide …

Objective To investigate the expression of short-chain fatty acids (SCFAs)—metabolites of
intestinal flora—in gestational complications of gestational diabetes mellitus (GDM) …

Over the past decades the potential role of the gut microbiome and bile acids in type 2
diabetes mellitus (T2DM) has been revealed, with a special reference to low bacterial alpha …

Primary biliary cholangitis (PBC) is an autoimmune liver disease with striking female
predisposition, and selective destruction of intrahepatic small bile ducts leading to non …

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease with ursodeoxycholic
acid (UDCA) as first-line treatment. Poor response to UDCA is associated with a higher risk …

The “Gut–Liver Axis” refers to the physiological bidirectional interplay between the gut and
its microbiota and the liver which, in health, occurs thanks to a condition of immune …

Background & Aims Gut dysbiosis and myeloid-derived suppressor cells (MDSCs) are
implicated in primary biliary cholangitis (PBC) pathogenesis. However, it remains unknown …